You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行》野村升藥明康德(02359.HK)目標價至102.77元 料公司上調2025財年收入指引
阿思達克 07-11 11:32
藥明康德(02359.HK)發盈喜,預計中期營業收入按年增長20.6%,即次季銷售額為111億元人民幣,高於預期。野村發表研究報告指,相信藥明康德錄得較高增長,可能是由於化學業務表現持續強勁及其他業務錄得改善。 野村各上調藥明康德今明兩年的收入預測3%,並調升盈測28%和4%。該行預計,公司將於今年下半年保持增長勢頭,料期內收入及盈測分別增長3%及18%,並相信公司將上調其今年全年收入指引。該行維持公司「買入」評級,將目標價由84.59港元升至102.77港元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account